OTCBB:SMLR
Delisted

Semler Scientific Stock News

etoro logo Buy SMLR
*Your capital is at risk
$20.35
+0 (+0%)
At Close: Apr 14, 2026
SANTA CLARA, Calif. , June 6, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chro
Semler Scientific has committed to a Bitcoin-based treasury plan, starting with a $40 million crypto investment. The stock surged 43% after this announcement.
SANTA CLARA, Calif. , May 28, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chro
Semler Scientific's primary product, QuantaFlo, is a fast and easy-to-use device for diagnosing peripheral arterial disease. Its stock has dropped nearly 50% in value, presenting a potential opportuni
Semler Scientific, Inc. (NASDAQ:SMLR ) Q1 2024 Results Conference Call May 7, 2024 4:30 PM ET Company Participants Doug Murphy-Chutorian - Chief Executive Officer Renae Cormier - Chief Financial Offic
2024 Q1 highlights compared to the corresponding period of 2023: First quarter revenues were $15.9 million, a decrease of 13% First quarter net income was $6.1 million, an increase of 22% Cash, cash e
SMLR has a competitive product (QuantaFlo) in the cardiovascular diagnostic space, and is currently awaiting a 510(k) clearance for expanded use, which could potentially arrive in H2-24. Semler's cash
SANTA CLARA, Calif. , April 23, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in e
With the market trading near all-time highs, undervalued healthcare stocks offer a compelling opportunity. Fundamentally, the sector could benefit from a rotation in the innovation ecosystem.
Semler Scientific, Inc. (NASDAQ:SMLR ) Q4 2023 Earnings Conference Call March 5, 2024 4:30 PM ET Company Participants Doug Murphy-Chutorian - Chief Executive Officer Renae Cormier - Chief Financial Of
2023 Q4 and full year highlights compared to the corresponding period of 2022: Fourth quarter revenues were $15.1 million, an increase of 9% Fourth quarter net income was $4.2 million, an increase of
SANTA CLARA, Calif. , Feb. 21, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in ev
Semler is a medtech company with high ROC, double-digit top-line growth, and a robust balance sheet. The company operates in the cardiovascular testing industry, primarily marketing the QuantaFlo bloo
The recent sell-off in tech stocks has left many high-quality names trading at sizable discounts. For long-term investors, this presents an intriguing opportunity to position one's portfolio for the n
Semler Scientific, Inc. (NASDAQ:SMLR ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Company Participants Doug Murphy-Chutorian – Chief Executive Officer Renae Cormier – Chief Finan
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE